32 research outputs found

    Comment les médecins nucléaires prennent-ils en compte les aspects éthiques dans la communication des résultats aux patients réalisant une TEP d'indication oncologique? Une étude nationale française

    No full text
    Objectif: There are no guidelines regarding the content of information to be delivered in nuclear medicine. This study aimed at describing practices of French nuclear medicine physicians concerning results communication to patients undergoing PETs for oncological indications. Methodes: A survey was performed among French nuclear medicine physicians using an electronic questionnaire. Resultats: The study included 250 nuclear medicine physicians. Their practices regarding communication of PET results to patients were heterogeneous: (1) pre- and/or post-PET consultations were systematic for 56%, adapted on a case-to-case basis for 35%, and never performed for 9% of respondents; (2) oral communication of results was systematic for 13%, adapted on a case-to-case basis for 63%, and never performed for 24% of respondents. Working in a private center, presence of post-PET consultations, being older and more years of experience were significantly associated with more oral communication of results. Finally, 80% of physicians admit that current recommendations are not clear enough. Conclusion: The heterogeneity of practices among French nuclear medicine physicians concerning communication of PET results to patients probably results from lack of clear recommendations. An inter-collegial, ethical, and multi-disciplinary reflection is needed to better guide nuclear medicine physicians in relation to the communication of results to patients suffering from serious disease.SCOPUS: sh.jinfo:eu-repo/semantics/publishe

    Illustrations pratiques – Produits de contraste iodĂ©s (PCI)

    No full text
    National audienceIodinated Contrast Agent (ICA) may be used in nuclear medicine for level 3 and 4 CT level. The use of ICA in SPECT/CT or PET/CT is driven, for each patient, by the clinical context, the benefit/risk ratio and the availability and the date of the previous injected CT. The improvement in diagnostic performance of the exam is the main goal of the ICA injection during a hybrid NM procedure. © 2018 Elsevier Masson SASL’administration de PCI en mĂ©decine nuclĂ©aire se conçoit dans le cadre de pratiques de TDM de niveaux 3 et 4. L’utilisation des PCI en mĂ©decine nuclĂ©aire dans le cadre des examens de TEMP/TDM ou TEP/TDM est soumise Ă  l’évaluation pour chaque patient du rapport bĂ©nĂ©fice–risque, tenant compte des examens qui ont dĂ©jĂ  eu lieu, de leurs rĂ©sultats et de leur disponibilitĂ©/accessibilitĂ© le jour de l’examen de MN. Les bĂ©nĂ©fices attendus d’une injection de PCI sont une amĂ©lioration globale des performances diagnostiques de l’examen

    Illustrations cliniques en oncologie

    No full text
    National audienceThe examples and clinical cases presented in this section are not intended to be considered as absolute models in terms of image quality or device parameter settings. They must initiate an individual analysis according to CT parameters and image quality. Nevertheless, they present practically different CT levels, which can be used according to the clinical context and the type of device. © 2018 Elsevier Masson SASLes exemples et les cas cliniques prĂ©sentĂ©s dans cette partie n’ont pas vocation Ă  ĂȘtre considĂ©rĂ©s comme des modĂšles absolus en termes de qualitĂ© image ou de paramĂ©trage des appareils. Les exemples doivent contribuer Ă  initier une rĂ©flexion individuelle concernant le paramĂ©trage du scanner en fonction de la situation clinique, du niveau de scanner que l’on souhaite rĂ©aliser et de l’appareillage dont on dispose. Ils permettent de prĂ©senter de maniĂšre concrĂšte, Ă  partir d’images de sĂ©lection, des exemples des diffĂ©rents niveaux de scanner envisageables dans une situation donnĂ©e
    corecore